| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.093 | 0.04 |